Mutual Fund Ownership
Ownership as on: Sat, 24 Feb, 2024

WhiteOak Capital Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)4.92
% of AUM5.78%

ITI Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)7.18
% of AUM4.74%

SBI Healthcare Opportunities Fund Regular Growth

NA
Equity
Amount Invested (Cr.)112.00
% of AUM4.61%

Invesco India Focused Fund Regular Growth

3/5
Equity
Amount Invested (Cr.)86.70
% of AUM4.09%

Motilal Oswal ELSS Tax Saver Fund Regular Plan Growth

4/5
Equity
Amount Invested (Cr.)106.00
% of AUM3.50%

FAQs about Mankind Pharma share price

Mankind Pharma is trading at 2153.75 as on Fri Feb 23 2024 09:59:25. This is -1.54% lower as compared to its previous closing price of 2187.45.

The market capitalization of Mankind Pharma is 86276.74 Cr as on Fri Feb 23 2024 09:59:25.

The average broker rating on Mankind Pharma is Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 5 analysts have given a buy rating
  • 4 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Mankind Pharma is 2297.00 whereas the 52 wk low is 1240.75

Mankind Pharma can be analyzed on the following key metrics -

  • TTM P/E: -
  • Sector P/E: 22.05
  • Dividend Yield: -%
  • D/E ratio: -

Mankind Pharma reported a net profit of 1281.86 Cr in 2023.

Recommended For You
Images
Trending Stocks
1,616.50+22.75(1.43%)
1,930.20+21.60(1.13%)
3,691.25+39.45(1.08%)
1,665.70-21.05 (-1.25%)
11,539.15-136.35 (-1.17%)